AVA-NEXTGENMONOCLONALS Trademark

Trademark Overview


On Thursday, October 24, 2019, a trademark application was filed for AVA-NEXTGENMONOCLONALS with the United States Patent and Trademark Office. The USPTO has given the AVA-NEXTGENMONOCLONALS trademark a serial number of 79273429. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 22, 2020. This trademark is owned by AVA Lifescience GmbH. The AVA-NEXTGENMONOCLONALS trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes; biological tissue cultures for medical purposes; biological preparations for medical purposes; diagnostic preparations; diagnostic biomarker reagents for medical purposes; diagnostic kits and testing systems, consisting of reagents for the medical diagnosis and analysis of bodily fluids for use in detecting diseases, in particular cancer; anticancer pharmaceutical compounds; anticancer pharmaceutical compounds; antibodies for human medicine, diagnostic or therapeutic purposes
ava-nextgenmonoclonals

General Information


Serial Number79273429
Word MarkAVA-NEXTGENMONOCLONALS
Filing DateThursday, October 24, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, September 22, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedicines for human purposes; biological tissue cultures for medical purposes; biological preparations for medical purposes; diagnostic preparations; diagnostic biomarker reagents for medical purposes; diagnostic kits and testing systems, consisting of reagents for the medical diagnosis and analysis of bodily fluids for use in detecting diseases, in particular cancer; anticancer pharmaceutical compounds; anticancer pharmaceutical compounds; antibodies for human medicine, diagnostic or therapeutic purposes
Pseudo MarkAVA-NEXT GEN MONOCLONALS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 9, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAVA Lifescience GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Sunday, October 10, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 22, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 22, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, May 23, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 5, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 5, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, September 22, 2020ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, September 22, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, March 27, 2020REFUSAL PROCESSED BY IB
Wednesday, March 11, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 11, 2020REFUSAL PROCESSED BY MPU
Tuesday, February 4, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 3, 2020NON-FINAL ACTION WRITTEN
Wednesday, January 29, 2020ASSIGNED TO EXAMINER
Friday, December 13, 2019APPLICATION FILING RECEIPT MAILED
Monday, December 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 5, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB